Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, February 10, 2010, 6:04pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares,
Register
FINANCE HOME PAGE
INVESTING
FINANCE NEWS
Enter symbol(s):
Market:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
|
Alphabetical List
Advaxis Inc. (ADXS.OB)
At 4:59AM SGT:
0.163 USD
0.00 (0.00%)
MORE ON ADXS.OB
Quotes
Summary
Options
Historical Prices
Charts
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
ADVAXIS INC
(OTC BB:ADXS.OB) Delayed quote data
Last Trade:
0.163 USD
Trade Time:
4:59AM SGT
Change:
0.00 (0.00%)
Prev Close:
0.163
Open:
N/A
Bid:
N/A
Ask:
N/A
1y Target Est:
N/A
Day's Range:
N/A - N/A
52wk Range:
0.02 - 0.21
Volume:
0
Avg Vol
(3m)
:
890,316
Market Cap:
18.85M
P/E
(ttm)
:
N/A
EPS
(ttm)
:
-0.014
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
Use Y! Toolbar to track stocks
Add ADXS.OB to Portfolio
Download Data
HEADLINES
Cancer Research UK to Fund Clinical Trial of ADXS11-001 for the Treatment of Head and Neck Cancer
Business Wire
(Wed 4:00am)
Advaxis to Present at the BIO CEO & Investor Conference
Business Wire
(Tue 3:53am)
ADVAXIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
EDGAR Online
(Sat, Feb 6)
Advaxis Chairman/CEO Thomas A. Moore Interviewed
Business Wire
(Tue, Feb 2)
Advaxis Receives $278,978 in Non-Dilutive Tax Credit Sale
Business Wire
(Thu, Jan 28)
Advaxis Issued New Intellectual Property Patent
Business Wire
(Fri, Jan 22)
ADVAXIS, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers
EDGAR Online
(Tue, Jan 12)
Advaxis to Present at the Sidoti Microcap 2010 Investor Conference
Business Wire
(Sat, Jan 9)
Advaxis Awarded European Patent for New Listeria Vector
Business Wire
(Mon, Jan 4)
Fifteen Percent of ADXS11-001 Treated Cervix Cancer Patients Still Alive Three Years after Initial Dosing
Business Wire
(Tue, Dec 29)
More Headlines for ADXS.OB...
BUSINESS SUMMARY
Advaxis, Inc., a development stage biotechnology company, engages in the research and development of new cancer-fighting techniques primarily in the United States.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
Latest News
Singapore Indices